Your browser doesn't support javascript.
loading
Subcutaneous daratumumab in patients with relapsed or refractory multiple myeloma: Part 2 of the open-label, multicenter, dose-escalation phase 1b study (PAVO).
San-Miguel, Jesus; Usmani, Saad Z; Mateos, Maria-Victoria; van de Donk, Niels W C J; Kaufman, Jonathan L; Moreau, Philippe; Oriol, Albert; Plesner, Torben; Benboubker, Lotfi; Liu, Kevin; Hellemans, Peter; Masterson, Tara; Clemens, Pamela L; Luo, Man; Farnsworth, Andrew; Nahi, Hareth; Chari, Ajai.
Afiliación
  • San-Miguel J; Clínica Universidad de Navarra-CIMA, IDISNA, CIBERONC, Pamplona, Spain.
  • Usmani SZ; Levine Cancer Institute/Atrium Health, Charlotte, NC, USA.
  • Mateos MV; University Hospital of Salamanca/IBSAL, Salamanca, Spain.
  • van de Donk NWCJ; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Hematology, Amsterdam, The Netherlands.
  • Kaufman JL; Winship Cancer Institute, Emory University, Atlanta, GA, USA.
  • Moreau P; University Hospital of Nantes, Nantes, France.
  • Oriol A; Institut Català d'Oncologia, HGTiP, Barcelona, Spain.
  • Plesner T; Vejle Hospital and University of Southern Denmark, Vejle, Denmark.
  • Benboubker L; Service d'Hématologie et Thérapie Cellulaire, Hôpital Bretonneau,Tours, France.
  • Liu K; Janssen Research and Development, LLC, Raritan, NJ, USA.
  • Hellemans P; Janssen Research and Development, Beerse, Belgium.
  • Masterson T; Janssen Research and Development, LLC, Spring House, PA, USA.
  • Clemens PL; Janssen Research and Development, LLC, Spring House, PA, USA.
  • Luo M; Janssen Research and Development, LLC, Spring House, PA, USA.
  • Farnsworth A; Janssen Research and Development, LLC, High Wycombe, United Kingdom.
  • Nahi H; Division of Hematology, Karolinska University Hospital at Huddinge, Stockholm, Sweden.
  • Chari A; Tisch Cancer Institute, Mount Sinai School of Medicine, New York, NY, USA.
Haematologica ; 106(6): 1725-1732, 2021 06 01.
Article en En | MEDLINE | ID: mdl-32354874

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Mieloma Múltiple Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Haematologica Año: 2021 Tipo del documento: Article País de afiliación: España Pais de publicación: Italia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Mieloma Múltiple Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Haematologica Año: 2021 Tipo del documento: Article País de afiliación: España Pais de publicación: Italia